N/A
Completed N=152
A Telehealth Advance Care Planning Intervention in Those With Mild Cognitive Impairment or Unrecognized Dementia
Advance Care Planning · Telemedicine · Mild Cognitive Impairment · Unrecognized Dementia
Source: ClinicalTrials.gov NCT04912245 ↗
Enrolled (actual)
152
Serious AEs
0.7%
Results posted
Mar 2023
Primary outcomePrimary: Number of Patient/Care Partner Agreeing to Participate — 152 Participants
Summary
The purpose of this study is to pilot test a telehealth Advance Care Planning (ACP) intervention among those with either mild cognitive impairment (MCI) or unrecognized dementia. Our goal is to pilot-test and evaluate a pragmatic Telehealth ACP intervention among patients with either the diagnosis of mild cognitive impairment (MCI) or unrecognized dementia.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patient/Care Partner Agreeing to Participate |
152 | — |
| PRIMARY Number of Participants With Telehealth Advance Care Planning (ACP) Completed |
111 | — |
| SECONDARY Number of Participants With One or More Advance Care Planning (ACP) Discussions |
81 | — |
| SECONDARY Number of Participants Who Used One or More Advance Care Planning (ACP) Billing Codes |
78 | — |
| SECONDARY Quality of Advance Care Planning (ACP) Discussion Scores |
7.7 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosis of recognized or probable Mild cognitive impairment (MCI) or mild dementia determined by either ICD10 diagnostic codes or electronic health record (EHR) Risk of Alzheimer's and Dementia Assessment Rule (eRADAR)
- Have decisional capacity according to their primary care physician (PCP) to complete ACP
- Completed visit with their PCP within the past 12 months
- Affiliated with an Accountable Care Organization.
- English-speaking
Exclusion Criteria
- Moderate to severe hearing loss that would preclude participating in a video or telephone intervention
- No phone number available for patient.
- Lives in a long-term care facility
Data sourced from ClinicalTrials.gov (NCT04912245). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.